600763 Stock Overview
Topchoice Medical Corporation provides medical services in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Topchoice Medical Co., Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥60.79 |
| 52 Week High | CN¥121.52 |
| 52 Week Low | CN¥52.24 |
| Beta | 0.44 |
| 1 Month Change | -2.52% |
| 3 Month Change | 1.32% |
| 1 Year Change | -49.00% |
| 3 Year Change | -80.59% |
| 5 Year Change | -21.05% |
| Change since IPO | 119.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600763 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 12.1% | 2.9% | 4.2% |
| 1Y | -49.0% | -33.5% | -13.2% |
Return vs Industry: 600763 underperformed the CN Healthcare industry which returned -33.5% over the past year.
Return vs Market: 600763 underperformed the CN Market which returned -13.2% over the past year.
Price Volatility
| 600763 volatility | |
|---|---|
| 600763 Average Weekly Movement | 6.7% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 600763 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600763's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 6,115 | Yi Wang | www.tcmedical.com.cn |
Topchoice Medical Corporation provides medical services in China. The company provides various medical services in the areas of oral, reproductive, health, and ophthalmology. It also operates dental medical institutions and hospitals.
Topchoice Medical Co., Inc. Fundamentals Summary
| 600763 fundamental statistics | |
|---|---|
| Market cap | CN¥19.44b |
| Earnings (TTM) | CN¥504.72m |
| Revenue (TTM) | CN¥2.88b |
38.5x
P/E Ratio6.7x
P/S RatioIs 600763 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600763 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.88b |
| Cost of Revenue | CN¥1.77b |
| Gross Profit | CN¥1.11b |
| Other Expenses | CN¥604.08m |
| Earnings | CN¥504.72m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.58 |
| Gross Margin | 38.49% |
| Net Profit Margin | 17.52% |
| Debt/Equity Ratio | 8.6% |
How did 600763 perform over the long term?
See historical performance and comparison